Claims
- 1. A compound of the formula ##STR22## in which R.sup.1 represents NO.sub.2 ; or a non-toxic metabolically labile ester or amide thereof; or a pharmaceutically acceptable salt thereof.
- 2. A compound according to claim 1 in which the compound is (1S*,2S*,4R*,5R*,6S*) 2-Amino-4-nitrobicyclo[3.1.0]hexane-2,6-dicarboxylic acid.
- 3. A pharmaceutical formulation, which comprises a compound as claimed in claim 1 and a pharmaceutically acceptable carrier, diluent or excipient.
- 4. A method of modulating metabotropic glutamate receptor function in a mammal which comprises administering an effective amount of a compound of formula I; or a non-toxic metabolically labile ester or amide thereof; or a pharmaceutically acceptable salt thereof.
CROSS REFERENCE
This application claims priority of Provisional Application Ser. No. 60/108,371, filed Nov. 13, 1998.
US Referenced Citations (5)
Number |
Name |
Date |
Kind |
5688826 |
Massey et al. |
Nov 1997 |
|
5750566 |
Monn et al. |
May 1998 |
|
5912248 |
Fernandez et al. |
Jun 1999 |
|
5916920 |
Fernandez et al. |
Jun 1999 |
|
5958960 |
Massey et al. |
Sep 1999 |
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
0 774 454 A1 |
May 1997 |
EPX |